Details about Nancy Devlin
Access statistics for papers by Nancy Devlin.
Last updated 2020-11-22. Update your information in the RePEc Author Service.
Short-id: pde347
Jump to Journal Articles Books
Working Papers
2020
- Anchoring Latent Scale Values for the EQ-5D-Y at 0 = Dead
Research Papers, Office of Health Economics
2019
- Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA
Research Papers, Office of Health Economics View citations (1)
- Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England
Research Papers, Office of Health Economics
- Public Preferences for Health Gains and Cures: A Discrete Choice Experiment
Consulting Reports, Office of Health Economics View citations (1)
- Valuing EQ-5D-Y Health States Using a Discrete Choice Experiment: Do Adult and Adolescent Preferences Differ?
Research Papers, Office of Health Economics View citations (1)
2018
- New Methods for Analysing the Distribution of EQ-5D Observations
Research Papers, Office of Health Economics View citations (1)
- Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology
Consulting Reports, Office of Health Economics
2017
- A New Valuation Method: Directly Eliciting Personal Utility Functions
Research Papers, Office of Health Economics View citations (1)
- Age and Utilities: Issues for HTA
Research Papers, Office of Health Economics
- Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets
Research Papers, Office of Health Economics View citations (1)
See also Journal Article in PharmacoEconomics (2018)
- What is the Normative Basis for Selecting the Measure of 'Average' Preferences for Use in Social Choices?
Research Papers, Office of Health Economics View citations (4)
2016
- "New Age" Decision Making in HTA: Is It Applicable in Asia?
Briefings, Office of Health Economics
- A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications
Research Papers, Office of Health Economics View citations (3)
- An Analysis of NICE Technology Appraisal Decisions 'Recommended in Line with Clinical Practice'
Research Papers, Office of Health Economics
- Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders' Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
Research Papers, Office of Health Economics 
See also Journal Article in PharmacoEconomics - Open (2018)
- New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data
Research Papers, Office of Health Economics View citations (14)
See also Journal Article in Health Economics (2018)
- Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making
Consulting Reports, Office of Health Economics View citations (1)
- The Distribution of the EQ-5D-5L Index in Patient Populations
Research Papers, Office of Health Economics
- Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England
Research Papers, Office of Health Economics View citations (45)
See also Journal Article in Health Economics (2018)
2015
- An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates
Research Papers, Office of Health Economics View citations (1)
- Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices?
Consulting Reports, Office of Health Economics View citations (3)
2014
- Opportunity Costs of Implementing NICE Decisions in NHS Wales
Research Papers, Office of Health Economics View citations (2)
- What Determines the Shape of an EQ-5D Index Distribution?
Research Papers, Office of Health Economics View citations (7)
2013
- A Study of the Relationship Between Health and Subjective Well-being in Parkinson's Disease Patients
Research Papers, Office of Health Economics View citations (1)
Also in Working Papers, Department of Economics, City University London (2013) View citations (2)
- Methods for the estimation of the NICE cost effectiveness threshold
Working Papers, Centre for Health Economics, University of York View citations (43)
- Searching for Cost-effectiveness Thresholds in NHS Scotland
Research Papers, Office of Health Economics View citations (1)
- The Influence of Cost-effectiveness and Other Factors on NICE Decisions
Research Papers, Office of Health Economics View citations (5)
Also in Working Papers, Centre for Health Economics, University of York (2013) View citations (11)
See also Journal Article in Health Economics (2015)
2012
- Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions
Working Papers, Centre for Health Economics, University of York View citations (1)
- Assessing the Performance of the EQ-VAS in the NHS PROMs Programme
Research Papers, Office of Health Economics View citations (1)
- Time Trends in NICE HTA Decisions
Consulting Reports, Office of Health Economics
- Time to tweak the TTO. But how?
MPRA Paper, University Library of Munich, Germany
- Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity
Research Papers, Office of Health Economics View citations (5)
2011
- Is the Aim of the Health Care System to Maximise QALYs? An Investigation of
Research Papers, Office of Health Economics View citations (2)
- Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches
Research Papers, Office of Health Economics View citations (1)
- The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response
Consulting Reports, Office of Health Economics View citations (6)
- Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes
Working Papers, Centre for Health Economics, University of York View citations (5)
See also Journal Article in Health Economics (2013)
2010
- A Comparison of Alternative Variants of the Lead and Lag Time TTO
Research Papers, Office of Health Economics View citations (2)
See also Journal Article in Health Economics (2013)
2009
- A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach
Working Papers, Department of Economics, City University London View citations (1)
See also Journal Article in Health Economics (2011)
- Does the value of quality of life depend on duration?
Working Papers, Department of Economics, City University London View citations (3)
- Using the EQ-5D as a performance measurement tool in the NHS
Working Papers, Department of Economics, City University London View citations (2)
2008
- A note on the nature of utility in time and health and implications for cost utility analysis
Working Papers, Department of Economics, City University London 
See also Journal Article in Social Science & Medicine (2009)
- Statistical analysis of EQ-5D profiles: does the use of value sets bias inference?
Working Papers, Department of Economics, City University London View citations (6)
2006
- The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis
Working Papers, Department of Economics, City University London
2005
- Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models
Working Papers, Department of Economics, City University London View citations (1)
2004
- A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study
Working Papers, Department of Economics, City University London View citations (1)
- Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis?
Working Papers, Department of Economics, City University London View citations (2)
See also Journal Article in Health Economics (2006)
2003
- Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis
Working Papers, Department of Economics, City University London View citations (3)
2000
- Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach
Treasury Working Paper Series, New Zealand Treasury
- The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs
Working Papers, Centre for Health Economics, University of York View citations (2)
Journal Articles
2020
- A new tool for creating personal and social EQ-5D-5L value sets, including valuing ‘dead’
Social Science & Medicine, 2020, 246, (C) View citations (1)
- An exploration of methods for obtaining 0 = dead anchors for latent scale EQ-5D-Y values
The European Journal of Health Economics, 2020, 21, (7), 1091-1103
- Do people with private health insurance attach a higher value to health than those without insurance? Results from an EQ-5D-5 L valuation study in Ireland
Health Policy, 2020, 124, (6), 639-646
- International Valuation Protocol for the EQ-5D-Y-3L
PharmacoEconomics, 2020, 38, (7), 653-663
- Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?
PharmacoEconomics, 2020, 38, (4), 325-340 View citations (1)
- The impact of price transparency on consumers and providers: A scoping review
Health Policy, 2020, 124, (8), 819-825
2019
- A new method for valuing health: directly eliciting personal utility functions
The European Journal of Health Economics, 2019, 20, (2), 257-270 View citations (6)
- All Male Panels and Other Diversity Considerations for ISPOR
PharmacoEconomics - Open, 2019, 3, (3), 423-426
- Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments
The European Journal of Health Economics, 2019, 20, (1), 99-105
2018
- 3L, 5L, What the L? A NICE Conundrum
PharmacoEconomics, 2018, 36, (6), 637-640 View citations (1)
- Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)
PharmacoEconomics - Open, 2018, 2, (2), 153-163 
See also Working Paper (2016)
- Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
PharmacoEconomics, 2018, 36, (6), 699-713 View citations (4)
See also Working Paper (2017)
- Correction to: 3L, 5L, What the L? A NICE Conundrum
PharmacoEconomics, 2018, 36, (6), 729-729 View citations (1)
- Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets
PharmacoEconomics, 2018, 36, (6), 727-727 View citations (1)
- New methods for modelling EQ‐5D‐5L value sets: An application to English data
Health Economics, 2018, 27, (1), 23-38 View citations (10)
See also Working Paper (2016)
- Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L
PharmacoEconomics, 2018, 36, (11), 1345-1353 View citations (3)
- Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment
The European Journal of Health Economics, 2018, 19, (4), 595-605 View citations (3)
- Valuing health‐related quality of life: An EQ‐5D‐5L value set for England
Health Economics, 2018, 27, (1), 7-22 View citations (11)
See also Working Paper (2016)
2017
- A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact?
Applied Health Economics and Health Policy, 2017, 15, (4), 469-477 View citations (3)
- Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial
The Patient: Patient-Centered Outcomes Research, 2017, 10, (6), 677-686
- EQ-5D and the EuroQol Group: Past, Present and Future
Applied Health Economics and Health Policy, 2017, 15, (2), 127-137 View citations (13)
- Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale
The European Journal of Health Economics, 2017, 18, (8), 967-977 View citations (1)
2015
- A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE)
PharmacoEconomics, 2015, 33, (8), 867-877 View citations (3)
- INTER‐PROVIDER COMPARISON OF PATIENT‐REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX
Health Economics, 2015, 24, (1), 41-54 View citations (1)
- Local health care expenditure plans and their opportunity costs
Health Policy, 2015, 119, (9), 1237-1244 View citations (4)
- The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions
Health Economics, 2015, 24, (10), 1256-1271 View citations (24)
See also Working Paper (2013)
2013
- A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO
Health Economics, 2013, 22, (5), 517-532 View citations (23)
See also Working Paper (2010)
- Lead versus lag-time trade-off variants: does it make any difference?
The European Journal of Health Economics, 2013, 14, (1), 25-31 View citations (2)
- One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands
The European Journal of Health Economics, 2013, 14, (1), 65-73 View citations (5)
- Operationalizing Value-Based Pricing of Medicines
PharmacoEconomics, 2013, 31, (1), 1-10 View citations (11)
- TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK‐ADJUSTED HOSPITAL COSTS AND PATIENTS' HEALTH OUTCOMES
Health Economics, 2013, 22, (8), 931-947 View citations (15)
See also Working Paper (2011)
- The development of new research methods for the valuation of EQ-5D-5L
The European Journal of Health Economics, 2013, 14, (1), 1-3 View citations (10)
- The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework
The European Journal of Health Economics, 2013, 14, (1), 15-24 View citations (2)
- Time to tweak the TTO: results from a comparison of alternative specifications of the TTO
The European Journal of Health Economics, 2013, 14, (1), 43-51 View citations (1)
2011
- A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach
Health Economics, 2011, 20, (3), 348-361 View citations (33)
See also Working Paper (2009)
2010
- An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions
PharmacoEconomics, 2010, 28, (11), 987-993 View citations (5)
- Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D data
Health Economics, 2010, 19, (8), 886-905 View citations (12)
2009
- A note on the nature of utility in time and health and implications for cost utility analysis
Social Science & Medicine, 2009, 68, (2), 362-367 View citations (7)
See also Working Paper (2008)
- Identifying the impact of government targets on waiting times in the NHS
Health Care Management Science, 2009, 12, (1), 1-10 View citations (34)
- Searching for cost effectiveness thresholds in the NHS
Health Policy, 2009, 91, (3), 239-245 View citations (26)
2007
- ‘Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data?’ a rejoinder
Health Economics, 2007, 16, (6), 649-651
2006
- "Yes", "No" or "Yes, but"? Multinomial modelling of NICE decision-making
Health Policy, 2006, 77, (3), 352-367 View citations (10)
- A theoretical framework for TTO valuations of health
Health Economics, 2006, 15, (10), 1149-1154 View citations (8)
- Is there a case for using visual analogue scale valuations in cost‐utility analysis?
Health Economics, 2006, 15, (7), 653-664 View citations (29)
See also Working Paper (2004)
2005
- A ‘new and improved’ EQ-5D valuation questionnaire?
The European Journal of Health Economics, 2005, 6, (1), 73-82 View citations (3)
- Continuity through change: The rhetoric and reality of health reform in New Zealand
Social Science & Medicine, 2005, 61, (2), 253-262 View citations (9)
2004
- Does NICE have a cost‐effectiveness threshold and what other factors influence its decisions? A binary choice analysis
Health Economics, 2004, 13, (5), 437-452 View citations (107)
- Getting Health Economics into Practice, Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1‐85775‐575‐8
Health Economics, 2004, 13, (5), 499-500
2003
- Logical inconsistencies in survey respondents' health state valuations ‐ a methodological challenge for estimating social tariffs
Health Economics, 2003, 12, (7), 529-544 View citations (17)
2002
- The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2001. No. of pages: 320. ISBN 0‐335‐20900‐9
Health Economics, 2002, 11, (6), 567-568
2001
- Health care spending and economic output: Granger causality
Applied Economics Letters, 2001, 8, (8), 561-564 View citations (42)
1999
- The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule
Social Science & Medicine, 1999, 49, (6), 763-779 View citations (2)
1996
- The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand
Health Policy, 1996, 38, (2), 101-115 View citations (6)
1995
- Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy?
Agenda - A Journal of Policy Analysis and Reform, 1995, 2, (2), 223-225
1994
- The effects of denturism: New Zealand dentists' response to competition
American Journal of Public Health, 1994, 84, (10), 1675-1677
Books
2011
- Incorporating Multiple Criteria in HTA: Methods and Processes
Monographs, Office of Health Economics View citations (29)
2010
- Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making
Monographs, Office of Health Economics View citations (10)
2004
- How Much Should We Spend on the NHS?
Monographs, Office of Health Economics View citations (1)
2002
- Cost-Effectiveness Thresholds: Economic and ethical issues
Monographs, Office of Health Economics View citations (13)
|
The links between different versions of a paper are constructed automatically by matching on the titles.
Please contact if a link is incorrect.
Use this form
to add links between versions where the titles do not match.
|